The stock of CryoPort Inc (CYRX) has gone down by -5.10% for the week, with a 10.43% rise in the past month and a -7.39% drop in the past quarter. The volatility ratio for the week is 8.62%, and the volatility levels for the past 30 days are 8.46% for CYRX. The simple moving average for the past 20 days is -1.27% for CYRX’s stock, with a -14.77% simple moving average for the past 200 days.
Is It Worth Investing in CryoPort Inc (NASDAQ: CYRX) Right Now?
Company’s 36-month beta value is 1.90.Analysts have differing opinions on the stock, with 4 analysts rating it as a “buy,” 2 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for CYRX is 48.29M, and currently, short sellers hold a 5.48% ratio of that floaft. The average trading volume of CYRX on May 22, 2025 was 543.63K shares.
CYRX) stock’s latest price update
The stock of CryoPort Inc (NASDAQ: CYRX) has decreased by -8.90 when compared to last closing price of 6.74.Despite this, the company has seen a loss of -5.10% in its stock price over the last five trading days. zacks.com reported 2025-05-12 that The mean of analysts’ price targets for CryoPort (CYRX) points to a 54.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Analysts’ Opinion of CYRX
Many brokerage firms have already submitted their reports for CYRX stocks, with UBS repeating the rating for CYRX by listing it as a “Buy.” The predicted price for CYRX in the upcoming period, according to UBS is $10 based on the research report published on March 24, 2025 of the current year 2025.
Guggenheim, on the other hand, stated in their research note that they expect to see CYRX reach a price target of $11. The rating they have provided for CYRX stocks is “Buy” according to the report published on December 19th, 2024.
Jefferies gave a rating of “Hold” to CYRX, setting the target price at $8 in the report published on August 07th of the previous year.
CYRX Trading at 2.02% from the 50-Day Moving Average
After a stumble in the market that brought CYRX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.30% of loss for the given period.
Volatility was left at 8.46%, however, over the last 30 days, the volatility rate increased by 8.62%, as shares surge +9.84% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -7.67% lower at present.
During the last 5 trading sessions, CYRX fell by -5.10%, which changed the moving average for the period of 200-days by -24.38% in comparison to the 20-day moving average, which settled at $6.22. In addition, CryoPort Inc saw -21.08% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CYRX starting from Sawicki Mark W, who sale 1,349 shares at the price of $6.94 back on Mar 24 ’25. After this action, Sawicki Mark W now owns 84,087 shares of CryoPort Inc, valued at $9,364 using the latest closing price.
STEFANOVICH ROBERT, the Chief Financial Officer of CryoPort Inc, sale 1,070 shares at $6.94 during a trade that took place back on Mar 24 ’25, which means that STEFANOVICH ROBERT is holding 190,349 shares at $7,428 based on the most recent closing price.
Stock Fundamentals for CYRX
Current profitability levels for the company are sitting at:
- -0.26 for the present operating margin
- 0.43 for the gross margin
The net margin for CryoPort Inc stands at -0.51. The total capital return value is set at -0.09. Equity return is now at value -24.08, with -12.77 for asset returns.
Based on CryoPort Inc (CYRX), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at -0.05. The debt to equity ratio resting at 0.61. The interest coverage ratio of the stock is -25.05.
Currently, EBITDA for the company is -78.61 million with net debt to EBITDA at -2.64. When we switch over and look at the enterprise to sales, we see a ratio of 2.39. The receivables turnover for the company is 7.57for trailing twelve months and the total asset turnover is 0.31. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.56.
Conclusion
In a nutshell, CryoPort Inc (CYRX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
